, Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents, 2017.

A. I. Van-sighem, T. S. Boender, and F. Wit, Human Immunodeficiency Virus (HIV) Infection in the Netherlands, 2016.

T. Amsterdam and . Netherlands, Available at: www.hiv-monitoring.nl, 2016.

P. W. Hunt, S. G. Deeks, and B. Rodriguez, Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy, AIDS, vol.17, pp.1907-1915, 2003.

L. Gras, A. M. Kesselring, and J. T. Griffin, CD4 cell counts of 800 cells/ mm 3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm 3 or greater, J Acquir Immune Defic Syndr, vol.45, pp.183-192, 2007.

N. Khanna, M. Opravil, and H. Furrer, CD4 + T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy, Clin Infect Dis, vol.47, pp.1093-1101, 2008.

R. D. Moore and J. C. Keruly, CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression, Clin Infect Dis, vol.44, pp.441-446, 2007.

K. N. Althoff, A. C. Justice, and S. J. Gange, Virologic and immunologic response to HAART, by age and regimen class, AIDS, vol.24, pp.2469-2479, 2010.

C. A. Sabin, C. J. Smith, and A. Monforte, Response to combination antiretroviral therapy: variation by age, AIDS, vol.22, pp.1463-1473, 2008.

V. Bouteloup, C. Sabin, and A. Mocroft, Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients, HIV Med, vol.18, pp.33-44, 2017.

K. Y. Smith, H. Valdez, and A. Landay, Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy, J Infect Dis, vol.181, pp.141-147, 2000.

L. Teixeira, H. Valdez, and J. Mccune, Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function, AIDS, vol.15, pp.1749-1756, 2001.

M. Provinciali, R. Moresi, and A. Donnini, Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly, Gerontology, vol.55, pp.314-321, 2009.

L. R. Bisset, T. L. Lung, and M. Kaelin, Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland, Eur J Haematol, vol.72, pp.203-212, 2004.

K. Jentsch-ullrich, M. Koenigsmann, and M. Mohren, Lymphocyte subsets' reference ranges in an age-and gender-balanced population of 100 healthy adults-a monocentric German study, Clin Immunol, vol.116, pp.192-197, 2005.

S. E. Mcnerlan, H. D. Alexander, and I. M. Rea, Age-related reference intervals for lymphocyte subsets in whole blood of healthy individuals, Scand J Clin Lab Invest, vol.59, pp.89-92, 1999.

P. Sansoni, A. Cossarizza, and V. Brianti, Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians

, Blood, vol.82, pp.2767-2773, 1993.

A. Santagostino, G. Garbaccio, and A. Pistorio, An Italian national multicenter study for the definition of a reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults, Haematologica, vol.84, pp.499-504, 1999.

Y. Bekele, Y. Mengistu, and T. R. De-wit, Timing of blood sampling for CD4 T-cell counting influences HAART decisions, Ethiop Med J, vol.49, pp.187-197, 2011.

F. Termorshuizen, R. B. Geskus, and M. T. Roos, Seasonal influences on immunological parameters in HIV-infected homosexual men: searching for the immunomodulating effects of sunlight, Int J Hyg Environ Health, vol.205, pp.379-384, 2002.

X. Anglaret, S. Diagbouga, and E. Mortier, CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients?, J Acquir Immune Defic Syndr Hum Retrovirol, vol.14, pp.361-367, 1997.

T. Messele, M. Abdulkadir, and A. L. Fontanet, Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts, Clin Exp Immunol, vol.115, pp.443-450, 1999.

S. Serrano-villar, S. Moreno, and M. Fuentes-ferrer, The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery, HIV Med, vol.15, pp.40-49, 2014.

S. Serrano-villar, M. J. Peree-elas, and F. Dronda, Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio, PLoS One, vol.9, p.85798, 2014.

J. Lo, S. Abbara, and L. Shturman, Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men, AIDS, vol.24, pp.243-253, 2010.

J. Strindhall, B. O. Nilsson, and S. Löfgren, No immune risk profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study, Exp Gerontol, vol.42, pp.753-761, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00499016

M. Buggert, J. Frederiksen, and K. Noyan, Multiparametric bioinformatics distinguish the CD4/CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection, J Immunol, vol.192, pp.2099-2108, 2014.

J. Frederiksen, M. Buggert, and K. Noyan, Multidimensional clusters of CD4+ T cell dysfunction are primarily associated with the CD4/CD8 ratio in chronic HIV infection, PLoS One, vol.10, pp.1-16, 2015.

S. Serrano-villar, C. Gutierrez, and A. Vallejo, The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression, J Infect, vol.66, pp.57-66, 2013.

R. A. Hughes, M. T. May, and K. Tilling, Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4:CD8 ratio, AIDS, vol.49, pp.1361-1367, 2018.

F. Caby, A. Guihot, and S. Lambert-niclot, Determinants of a low CD4/ CD8 ratio in HIV-1-infected individuals despite long-term viral suppression, Clin Infect Dis, vol.62, pp.1297-1303, 2016.

F. Caby, CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals, AIDS, vol.31, pp.1685-1695, 2017.

M. Egger, M. May, and G. Chêne, Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, Lancet, vol.360, pp.119-129, 2002.

D. Bates, M. Maechler, and B. Bolker, Fitting linear mixed-effects models using lme4, J Stat Softw, vol.67, pp.1-48, 2015.

. R-core-team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing

H. Kulkarni, J. F. Okulicz, and G. Grandits, Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-positive subjects receiving antiretroviral therapy, J Acquir Immune Defic Syndr, vol.57, pp.387-395, 2011.

O. Stirrup, A. Copas, and A. Phillips, Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion, HIV Med, vol.19, pp.184-194, 2018.

N. Langebeek, E. H. Gisolf, and P. Reiss, Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis, BMC Med, vol.12, p.142, 2014.

K. B. Patterson, S. E. Cohn, and J. Uyanik, Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies, Clin Infect Dis, vol.49, pp.473-476, 2009.

G. A. Calvet, L. Velasque, and P. M. Luz, Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil, PLoS One, vol.9, pp.8-13, 2014.

M. Helleberg, G. Kronborg, and H. Ullum, Course and clinical significance of CD8+ T-cell counts in a large cohort of HIV-infected individuals, J Infect Dis, vol.211, pp.1726-1734, 2015.

L. Wittkop, J. Bitard, and L. E. , Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected Patients: the ANRS CO3 aquitaine cohort, J Infect Dis, vol.207, pp.822-827, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01101196

S. G. Deeks, HIV infection, inflammation, immunosenescence, and aging, Annu Rev Med, vol.62, pp.141-155, 2013.

S. G. Deeks, R. Tracy, and D. C. Douek, Systemic effects of inflammation on health during chronic HIV infection, Immunity, vol.39, pp.633-645, 2013.

A. Mocroft, H. J. Furrer, and J. M. Miro, The incidence of AIDS-defining illnesses at a current CD4 count $ 200 cells/mL in the post-combination antiretroviral therapy era, Clin Infect Dis, vol.57, pp.1038-1047, 2013.

J. Young, CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE, PLoS Med, vol.9, p.1001194, 2012.

S. Serrano-villar, T. Sainz, and S. A. Lee, HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality, PLoS Pathog, vol.10, p.1004078, 2014.

A. Trickey, M. T. May, and P. Schommers, CD4:CD8 ratio and CD8 count as prognostic markers for mortality in human immunodeficiency virusinfected patients on antiretroviral therapy: the antiretroviral therapy cohort collaboration (ART-CC), Clin Infect Dis, vol.65, pp.959-966, 2017.

E. M. Bosire, A. K. Nyamache, and M. M. Gicheru, Population specific reference ranges of CD3, CD4 and CD8 lymphocyte subsets among healthy Kenyans, AIDS Res Ther, vol.10, p.24, 2013.